Kite, a Gilead Sciences company, recently reported new analysis showing that its CAR T therapy Yescarta delivers consistent ...

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

By shutting South Africa out of its overseas funding for the roll-out of the revolutionary six-monthly HIV prevention jab which could potentially end Aids, the Trump administration undercuts its own ...

If injectable medication to prevent infection, which has gained favour across Canada, were widely available in B.C., it would ...

Carlton V. Bell II won second place in GLAAD + STARZ TV Pilot Pitch Competition with a series that will destigmatize HIV.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...

The Executive Director of UNAIDS Winnie Byanyima made the call during the African AIDS conference ICASA in Accra, Ghana saying "ending AIDS is a political choice" ACCRA/GENEVA, 10 December ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best pharma stocks to invest in. Cantor Fitzgerald analyst Carter Gould ...

Finding the best blue-chip stocks to buy is never a simple task, especially when markets are shifting. Economic uncertainty, changing interest-rate expectations and the rapid evolution of ...

South Africa, Eswatini and Zambia in December began administering a groundbreaking HIV-prevention injection in the drug's ...